V-Capital: A global investment advisory firm, transforming Chinese enterprises through strategic M&A solutions.
Location
Shanghai, CN
Founded
2015
V-Capital is a global investment advisory firm focused on supporting Chinese enterprises through strategic mergers and acquisitions (M&A) and other cooperative methods. They invest globally based on client demands, providing strategic advice and solutions to Chinese public corporations, private enterprises, and other institutions. V-Capital typically participates in Series A and Series B investment rounds.
Notable portfolio companies include Cloudbreak Therapeutics, which has raised $25.4 million, Fogarty Institute For Innovation with $5 million raised, and Raydiant Oximetry, also raising $5 million. V-Capital's investment philosophy centers on transforming and upgrading enterprises through strategic M&A. The firm offers unique value-add services, leveraging its global reach and deep expertise to deliver tailored strategic advice and solutions.
V-Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Series A2 (66.7%)
Series B1 (33.3%)
Stage Mix
Series A 67%Series B 33%
Concentration shown as share of disclosed investments by stage.
